1. Home
  2. AFJK vs ZYXI Comparison

AFJK vs ZYXI Comparison

Compare AFJK & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFJK
  • ZYXI
  • Stock Information
  • Founded
  • AFJK 2023
  • ZYXI 1996
  • Country
  • AFJK United States
  • ZYXI United States
  • Employees
  • AFJK N/A
  • ZYXI N/A
  • Industry
  • AFJK
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AFJK
  • ZYXI Health Care
  • Exchange
  • AFJK NYSE
  • ZYXI Nasdaq
  • Market Cap
  • AFJK 68.6M
  • ZYXI 66.5M
  • IPO Year
  • AFJK 2023
  • ZYXI N/A
  • Fundamental
  • Price
  • AFJK $11.14
  • ZYXI $2.34
  • Analyst Decision
  • AFJK
  • ZYXI Buy
  • Analyst Count
  • AFJK 0
  • ZYXI 3
  • Target Price
  • AFJK N/A
  • ZYXI $6.00
  • AVG Volume (30 Days)
  • AFJK 14.9K
  • ZYXI 170.3K
  • Earning Date
  • AFJK 01-01-0001
  • ZYXI 07-24-2025
  • Dividend Yield
  • AFJK N/A
  • ZYXI N/A
  • EPS Growth
  • AFJK N/A
  • ZYXI N/A
  • EPS
  • AFJK N/A
  • ZYXI N/A
  • Revenue
  • AFJK N/A
  • ZYXI $172,401,000.00
  • Revenue This Year
  • AFJK N/A
  • ZYXI N/A
  • Revenue Next Year
  • AFJK N/A
  • ZYXI $19.55
  • P/E Ratio
  • AFJK $45.11
  • ZYXI N/A
  • Revenue Growth
  • AFJK N/A
  • ZYXI N/A
  • 52 Week Low
  • AFJK $10.24
  • ZYXI $1.66
  • 52 Week High
  • AFJK $11.20
  • ZYXI $10.62
  • Technical
  • Relative Strength Index (RSI)
  • AFJK N/A
  • ZYXI 48.62
  • Support Level
  • AFJK N/A
  • ZYXI $2.21
  • Resistance Level
  • AFJK N/A
  • ZYXI $2.66
  • Average True Range (ATR)
  • AFJK 0.00
  • ZYXI 0.19
  • MACD
  • AFJK 0.00
  • ZYXI 0.05
  • Stochastic Oscillator
  • AFJK 0.00
  • ZYXI 47.54

About AFJK AIMEI HEALTH TECHNOLOGY CO LTD

Aimei Health Technology Co Ltd is a blank check company.

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: